(Total Views: 389)
Posted On: 12/10/2020 9:13:38 AM
Post# of 36568
They aren’t the same.
$SLS = E75 peptide (NeuVax)
$GLSI = GP2 peptide
$GNBT = AE37 peptide
AE37 is unique in stimulating CD4 T cells as well as CD8 for a far longer lasting effect. E75 and GP2 ctl CD8 only. AE37 was looked at to be a combo approach to make them stronger. The AE37 combo vaccine from 2008 was AE37 as a doublet peptide with GP2. Early work by COL George Peoples wanted to do the same for E75. But Generex is studying a better approach with Keytruda. I’m sure if they pony up enough money Joe would let them license to try, but checkpoint inhibitors etc is the more realistic path. Jmho
$SLS = E75 peptide (NeuVax)
$GLSI = GP2 peptide
$GNBT = AE37 peptide
AE37 is unique in stimulating CD4 T cells as well as CD8 for a far longer lasting effect. E75 and GP2 ctl CD8 only. AE37 was looked at to be a combo approach to make them stronger. The AE37 combo vaccine from 2008 was AE37 as a doublet peptide with GP2. Early work by COL George Peoples wanted to do the same for E75. But Generex is studying a better approach with Keytruda. I’m sure if they pony up enough money Joe would let them license to try, but checkpoint inhibitors etc is the more realistic path. Jmho
(3)
(0)
